Cargando…
Biologics in COVID-19 So Far: Systematic Review
This systematic review aimed to reevaluate the available evidence of the use of biologics as treatment candidates for the treatment of severe and advanced COVID-19 disease; what are the rationale for their use, which are the most studied, and what kind of efficacy measures are described? A search th...
Autores principales: | Arias, Milton, Oliveros, Henry, Lechtig, Sharon, Bustos, Rosa-Helena |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9321859/ https://www.ncbi.nlm.nih.gov/pubmed/35890081 http://dx.doi.org/10.3390/ph15070783 |
Ejemplares similares
-
Isolated left ventricular apical hypoplasia: Systematic review and analysis of the 37 cases reported so far
por: Bassareo, Pier Paolo, et al.
Publicado: (2023) -
Mpox Person-to-Person Transmission—Where Have We Got So Far? A Systematic Review
por: Pinto, Pedro, et al.
Publicado: (2023) -
Neutrophils and COVID-19: The road so far
por: Cavalcante-Silva, Luiz Henrique Agra, et al.
Publicado: (2021) -
Carbapenem Therapeutic Drug Monitoring in Critically Ill Adult Patients and Clinical Outcomes: A Systematic Review with Meta-Analysis
por: Lechtig-Wasserman, Sharon, et al.
Publicado: (2021) -
Complement Inhibition and COVID-19: The Story so Far
por: Fodil, Sofiane, et al.
Publicado: (2021)